Estelle G. McLean

Characterization of p53 Wild-Type and Null Isogenic Colorectal Cancer Cell Lines Resistant to 5-Fluorouracil, Oxaliplatin, and Irinotecan

John Boyer, Estelle G. McLean, Somaiah Aroori et al. · Clinical Cancer Research · 2004 · 221 citations

Kinetic and Structural Characteristics of the Inhibition of Enoyl (Acyl Carrier Protein) Reductase by Triclosan

Walter H.J. Ward, Geoffrey A. Holdgate, Siân Rowsell et al. · Biochemistry · 1999 · 159 citations

Structural Characteristics, Acyl Carrier Protein, Biochemistry +15

Pharmacogenomic Identification of Novel Determinants of Response to Chemotherapy in Colon Cancer

John Boyer, Wendy L. Allen, Estelle G. McLean et al. · Cancer Research · 2006 · 106 citations

The role of spermidine/spermine<i>N</i>1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells

Wendy L. Allen, Estelle G. McLean, John Boyer et al. · Molecular Cancer Therapeutics · 2007 · 47 citations

Prostate-derived factor—a novel inhibitor of drug-induced cell death in colon cancer cells

Irina Proutski, Leanne Stevenson, Wendy L. Allen et al. · Molecular Cancer Therapeutics · 2009 · 20 citations

Chemoprevention Strategy, Apoptosis, Pdf Gene +19